SCHEMBL24458779

SCHEMBL24458779

C=CC(=O)N1C[C@@H]2[C@@H](C#Cc3c(-c4ccc(Oc5ccccc5)c(OC)c4)c4c(N)ncnc4n3C)[C@@H]2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITK Q08881 3/20 0.46
▸ EGFR P00533 5/20 0.46
▸ BTK Q06187 15/20 0.45
▸ FGFR2 P21802 3/20 0.45
▸ FGFR1 P11362 3/20 0.45
▸ FGFR3 P22607 1/20 0.45
▸ BMX P51813 4/20 0.43
▸ TEC P42680 3/20 0.43
▸ TXK P42681 2/20 0.43
▸ LYN P07948 2/20 0.43
▸ HCK P08631 2/20 0.43
▸ SRC P12931 2/20 0.43
▸ BLK P51451 2/20 0.43
▸ RIPK2 O43353 1/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ SLC22A3 O75751 1/20 0.43
▸ LATS1 O95835 1/20 0.43
▸ NUDT14 O95848 1/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ ERBB2 P04626 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31523792 1.00 ITK (0.46) ITKEGFRBTKFGFR2FGFR1
SCHEMBL31523992 0.90 BTK (0.53) ITKEGFRBTKFGFR2BMX
SCHEMBL31523754 0.89 ITK (0.44) ITKEGFRBTKFGFR2FGFR1
SCHEMBL24459006 0.89 ITK (0.44) ITKEGFRBTKFGFR2FGFR1
SCHEMBL31523756 0.88 RET (0.48) ITKBTKFGFR2FGFR1FGFR3
SCHEMBL24458389 0.88 RET (0.48) ITKBTKFGFR2FGFR1FGFR3
SCHEMBL24459042 0.87 BTK (0.50) ITKEGFRBTKFGFR2FGFR1
SCHEMBL24458947 0.87 BTK (0.48) ITKEGFRBTKFGFR2FGFR1
SCHEMBL31523936 0.87 BTK (0.48) ITKEGFRBTKFGFR2FGFR1
SCHEMBL24459014 0.85 ITK (0.46) ITKEGFRBTKFGFR2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109551-A1 SRC INHIBITORS AND USES THEREOF RELAY THERAPEUTICS, INC. (US) 2022-05-27 — — WO disclosed
Send feedback